• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者社会功能评定量表的编制。

The Development of the Social Functioning Scale for Patients with Parkinson's Disease.

机构信息

Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.

出版信息

J Parkinsons Dis. 2020;10(3):1143-1151. doi: 10.3233/JPD-201930.

DOI:10.3233/JPD-201930
PMID:32444559
Abstract

BACKGROUND

Social functioning is crucial for the determinants of Parkinson's disease (PD) with dementia; however, there is no social functioning scale applicable to PD.

OBJECTIVE

This study aimed to develop a social functioning scale specific to PD (PDSFS) and provide a cut-off score to improve diagnosis accuracy.

METHODS

The items were developed through literature, interview patients, and PD expertise. After the pilot study, one hundred fifty-seven patients and 74 healthy participants were enrolled and completed the Mini-Mental State Examination, Clock Drawing Test, Activities of Daily Living, Neuropsychiatric Inventory, Adaptive Behavior Assessment System-Second Edition (ABAS-II) and part III of the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS).

RESULTS

The final PDSFS has 23 items. The exploratory factor analysis revealed three factors, including "Family Life, Hobbies and Self-Care", "Interpersonal Relationship and Recreational Leisure", and "Social Bond". The internal consistency coefficient was 0.883, and the test-retest reliability was 0.774, respectively. The total score of the PDSFS was significantly related to the total score of ABAS-II (r = 0.609, p < 0.001), and was not correlated with the third part of MDS-UPDRS (p = 0.736). A significant intergroup difference was found (p < 0.001), and the healthy controls had the highest PDSFS score, followed by non-demented PD and PD dementia. The optimal cut-off score for PD patients with dementia was 39 (sensitivity: 0.735; specificity: 0.857).

CONCLUSIONS

PDSFS is a practical and psychometrically sound tool to access the social functioning of the PD population.

摘要

背景

社会功能对于帕金森病(PD)伴痴呆的决定因素至关重要;然而,目前尚无适用于 PD 的社会功能量表。

目的

本研究旨在开发一种特定于 PD 的社会功能量表(PDSFS),并提供一个截断分数以提高诊断准确性。

方法

通过文献、访谈患者和 PD 专业知识开发项目。在试点研究之后,纳入了 157 名患者和 74 名健康参与者,并完成了简易精神状态检查、画钟试验、日常生活活动能力量表、神经精神问卷、适应行为评估系统第二版(ABAS-II)和运动障碍协会赞助的统一帕金森病评定量表第三部分修订版(MDS-UPDRS)。

结果

最终的 PDSFS 有 23 个项目。探索性因子分析显示,该量表包含三个因子,分别为“家庭生活、爱好和自我护理”、“人际关系和娱乐休闲”和“社会联系”。内部一致性系数为 0.883,重测信度为 0.774。PDSFS 总分与 ABAS-II 总分显著相关(r=0.609,p<0.001),与 MDS-UPDRS 第三部分不相关(p=0.736)。组间差异有统计学意义(p<0.001),健康对照组的 PDSFS 得分最高,其次是非痴呆 PD 组和 PD 痴呆组。PD 痴呆患者的最佳截断分数为 39(灵敏度:0.735;特异性:0.857)。

结论

PDSFS 是一种实用且具有良好心理测量学特性的工具,可用于评估 PD 人群的社会功能。

相似文献

1
The Development of the Social Functioning Scale for Patients with Parkinson's Disease.帕金森病患者社会功能评定量表的编制。
J Parkinsons Dis. 2020;10(3):1143-1151. doi: 10.3233/JPD-201930.
2
Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.帕金森病认知评定量表在伊朗特发性帕金森病患者中的信度、效度和诊断准确性。
Disabil Rehabil. 2022 May;44(10):2091-2098. doi: 10.1080/09638288.2020.1813337. Epub 2020 Sep 14.
3
Investigating the interaction between neuropsychiatry features and daily activities on social function in patients with Parkinson's disease with mild cognitive impairment.探究帕金森病伴轻度认知障碍患者神经精神症状与日常活动对社会功能的相互作用。
BJPsych Open. 2022 Nov 25;8(6):e205. doi: 10.1192/bjo.2022.611.
4
Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.蒙特利尔认知评估量表、简易精神状态检查和 SCOPA-Cog 在非痴呆帕金森病患者中的变化反应性。
Dement Geriatr Cogn Disord. 2019;47(4-6):187-197. doi: 10.1159/000496454. Epub 2019 Jul 17.
5
Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.帕金森病患者中蒙特利尔认知评估量表(MoCA-P)波斯语版本的有效性和可靠性。
Appl Neuropsychol Adult. 2020 Sep-Oct;27(5):431-439. doi: 10.1080/23279095.2019.1565762. Epub 2019 Mar 1.
6
Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale.帕金森病认知功能评定量表意大利文版的验证。
J Neural Transm (Vienna). 2024 Apr;131(4):305-314. doi: 10.1007/s00702-024-02746-6. Epub 2024 Jan 27.
7
Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.验证蒙特利尔认知评估量表(MoCA-TR)土耳其语版本在帕金森病患者中的应用。
Clin Neuropsychol. 2014;28(2):333-43. doi: 10.1080/13854046.2014.881554. Epub 2014 Feb 17.
8
A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.一种用于帕金森病痴呆日常生活活动功能的高效筛查工具。
J Clin Exp Neuropsychol. 2020 Oct;42(8):867-879. doi: 10.1080/13803395.2020.1825634. Epub 2020 Oct 12.
9
The interlocking finger test in patients with Parkinson's disease and healthy subjects.帕金森病患者与健康受试者的扣指试验。
J Clin Neurosci. 2016 Jul;29:145-8. doi: 10.1016/j.jocn.2015.09.026. Epub 2016 Mar 5.
10
Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.帕金森病的认知筛查:帕金森神经心理痴呆评估(PANDA)与其他3种简短量表的比较
Rev Neurol (Paris). 2016 Feb;172(2):138-45. doi: 10.1016/j.neurol.2015.08.004. Epub 2015 Oct 20.

引用本文的文献

1
Updates on Parkinson's Disease.帕金森病的最新进展
Neuropsychiatr Dis Treat. 2025 Sep 4;21:1945-1953. doi: 10.2147/NDT.S540718. eCollection 2025.
2
A domain-based framework for cognitive profile identification in Parkinson's disease across diverse samples.一种基于领域的框架,用于跨不同样本识别帕金森病的认知概况。
Front Neuroanat. 2025 Jun 19;19:1566835. doi: 10.3389/fnana.2025.1566835. eCollection 2025.
3
Effectiveness of the Roy adaptation model-based nursing intervention in improving physiological, psychological, and social outcomes in patients with Parkinson's disease.
基于罗伊适应模式的护理干预对改善帕金森病患者生理、心理和社会结局的有效性。
BMC Neurol. 2025 May 24;25(1):219. doi: 10.1186/s12883-025-04232-2.
4
Impact of action observation therapy on motor and cognitive outcomes in older adults with mild cognitive impairment: a randomized controlled study.动作观察疗法对轻度认知障碍老年人运动和认知结局的影响:一项随机对照研究。
Front Public Health. 2025 Feb 21;13:1518092. doi: 10.3389/fpubh.2025.1518092. eCollection 2025.
5
Baseline liver fibrosis-4 score correlates to the progression of anxiety and cognitive impairment in patients with Parkinson's disease.基线肝纤维化-4评分与帕金森病患者焦虑和认知障碍的进展相关。
Front Aging Neurosci. 2025 Jan 24;17:1501319. doi: 10.3389/fnagi.2025.1501319. eCollection 2025.
6
Disgust-specific impairment of facial emotion recognition in Parkinson's disease patients with mild cognitive impairment.帕金森病伴轻度认知障碍患者面部情绪识别的厌恶特异性损害。
Soc Cogn Affect Neurosci. 2024 Nov 5;19(1). doi: 10.1093/scan/nsae073.
7
Investigating the interaction between neuropsychiatry features and daily activities on social function in patients with Parkinson's disease with mild cognitive impairment.探究帕金森病伴轻度认知障碍患者神经精神症状与日常活动对社会功能的相互作用。
BJPsych Open. 2022 Nov 25;8(6):e205. doi: 10.1192/bjo.2022.611.
8
Mild cognitive impairment in patients with Parkinson's disease: An updated mini-review and future outlook.帕金森病患者的轻度认知障碍:最新小型综述与未来展望
Front Aging Neurosci. 2022 Sep 6;14:943438. doi: 10.3389/fnagi.2022.943438. eCollection 2022.
9
A New Instrument Combines Cognitive and Social Functioning Items for Detecting Mild Cognitive Impairment and Dementia in Parkinson's Disease.一种新型仪器结合认知和社会功能项目以检测帕金森病中的轻度认知障碍和痴呆。
Front Aging Neurosci. 2022 Jun 16;14:913958. doi: 10.3389/fnagi.2022.913958. eCollection 2022.